MSF: New medicine deal is a short-term solution for people with TB

J&J must end its patent monopoly on bedaquiline so generic versions of this lifesaving drug can be widely produced Stop TB Partnership’s Global Drug Facility announcement yesterday of a deal with US pharmaceutical corporation Johnson & Johnson (J&J) to provide access to affordable generic versions of lifesaving tuberculosis (TB) drug bedaquiline will only offer a…